Conclusion
Our work is the first to analyze demography of cancer incidence rates
relative to the prevalence of CMV seropositivity both in U.S.
race/ethnic groups and worldwide. A biological connection between the
ubiquity of CMV and the incidence of neoplasms is predicated by a
worldwide correlation between the two. This result may further inspire
an oncologic initiative for development of the CMV-based antitumor
vaccine constructs that could result in a significant reduction of human
cancers the world over. Here, we aimed at just this.